RNS Number : 3081B

Indivior PLC

19 September 2018

Indivior PLC (the 'Company')

Indivior PLC confirms that Mr Howard Pien, Non-Executive Chairman, was appointed as an independent director of Idera Pharmaceuticals, Inc., a specialty pharmaceutical company listed on the NASDAQ Stock Market, with effect from September 18, 2018.

This announcement is made in accordance with Listing Rule 9.6.14.

Kathryn Hudson

Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RDNFKCDNQBKDPCD